Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): a study comparing FH individuals in UK primary care and the UK Simon Broome register linked with secondary care records

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): a study comparing FH individuals in UK primary care and the UK Simon Broome register linked with secondary care records

Bibliographic Details
Main Authors:	B. Iyen, N. Qureshi, P. Roderick, N. Capps, P.N. Durrington, I.F.W. McDowell, J. Cegla, H. Soran, J. Schofield, H.A.W. Neil, J. Kai, S. Weng, S.E. Humphries
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	Atherosclerosis Plus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667089522000293

Similar Items

Reduction in cardiovascular disease morbidity of men and women with familial hypercholesterolaemia (FH) associated with availability of high intensity statins: A cohort study using data from the UK Simon Broome Register linked with secondary care records
by: B. Iyen, et al.
Published: (2021-09-01)

Does socioeconomic status have an effect on the treatment and outcomes of individuals with familial hypercholesterolaemia (FH)? : a cohort study of individuals with FH in UK primary care
by: B. Iyen, et al.
Published: (2021-09-01)

Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK Biobank
by: J. Gratton, et al.
Published: (2022-10-01)

How many homozygous Familial Hypercholesterolaemia (FH) patients are there likely to be in the UK? : The FH phenotype caused by the APOB p.(Arg3527Trp) variant in a South Asian family
by: I. Tracey, et al.
Published: (2022-10-01)

Elevated lipoprotein(a) levels in Familial Hypercholesterolaemia (FH): prevalence and implications for FH clinical diagnosis
by: A. David, et al.
Published: (2023-12-01)

CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
by: Seed, M, et al.
Published: (2011)

Prevalence of familial hypercholesterolaemia (FH)-causing variants and impact on LDL-C concentration in European, South Asian, and African ancestry groups of the UK Biobank
by: J. Gratton, et al.
Published: (2023-12-01)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
by: Seed, M, et al.
Published: (2009)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
by: Seed, M, et al.
Published: (2009)

A novel combinatorial non-viral vector to treat familial hypercholesterolaemia (FH)
by: Kerr, A, et al.
Published: (2016)

How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?
by: S.E. Humphries, et al.
Published: (2023-12-01)

Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
by: Ingunn Molven, et al.
Published: (2013-01-01)

Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation
by: P Sharma, et al.
Published: (2012-03-01)

Identification of FH-causing variants in patients with clinical familial hypercholesterolaemia recruited into the 100,000 genome project: preliminary analysis
by: A. Rimbert, et al.
Published: (2021-09-01)

How many FH genetic tests were performed by the UK Genetic Laboratory Hubs in 2022?
by: S.E. Humphries, et al.
Published: (2023-12-01)

Probable maximum flood: the potential for estimation in the UK using ReFH2
by: Tracey Haxton, et al.
Published: (2023-03-01)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
by: Neil, A, et al.
Published: (2008)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, A, et al.
Published: (2008)

19. Using a novel combinatorial non-viral vector and small molecules to treat familial hypercholesterolaemia (FH)
by: Kerr, A, et al.
Published: (2016)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
by: Humphries, SE, et al.
Published: (2005)

DEVELOPMENT OF AN AFFORDABLE, SENSITIVE AND RAPID SCREENING METHOD FOR MUTATION DETECTION IN UK FH SUBJECTS
by: Scartezini, M, et al.
Published: (2008)

A novel mutation in exon 5 of the low density lipoprotein receptor gene in a Malay family with familial hypercholesterolaemia (FH)
by: Abdul Murad N. A.,, et al.
Published: (2013)

The Succinated Proteome of FH-Mutant Tumours.
by: Yang, M, et al.
Published: (2014)

IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)
by: Descamps, O, et al.
Published: (2010)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
by: Laney K. Jones, et al.
Published: (2022-04-01)

The Succinated Proteome of FH-Mutant Tumours
by: Ming Yang, et al.
Published: (2014-08-01)

A comparative sequence analysis reveals a common GBD/FH3-FH1-FH2-DAD architecture in formins from <it>Dictyostelium</it>, fungi and metazoa
by: Uyeda Taro QP, et al.
Published: (2005-03-01)

El género Agaricus L. : Fr. - Agaricus luteomaculatus (F.H. Möller) F.H. Möller.
by: ARRILLAGA, P., LASKIBAR, X.
Published: (2002-01-01)

The development of a theory informed behaviour change intervention to improve adherence to dietary and physical activity treatment guidelines in individuals with familial hypercholesterolaemia (FH)
by: F. J. Kinnear, et al.
Published: (2020-01-01)

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
by: R. H. Fairoozy, et al.
Published: (2017-12-01)

F.H. Bradley as theological utilitarian
by: Crisp, R
Published: (2021)

Adaptive FH-SVM for Imbalanced Classification
by: Qi Wang, et al.
Published: (2019-01-01)

Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
by: Lakshmi Lavanya Reddy, et al.
Published: (2022-01-01)

Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
by: Isabella Costa, et al.
Published: (2014-10-01)

15 Jahre Weiterbildung an der FH Erfurt
by: Brit Arnold
Published: (2020-09-01)

Mechanisms of FH Protection Against Neovascular AMD
by: Céline Borras, et al.
Published: (2020-04-01)

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.
by: Humphries, SE, et al.
Published: (2006)

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
by: Neil, H, et al.
Published: (1999)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, H, et al.
Published: (2005)

FH deficient uterine leiomyomas-a case series
by: Meenakshi Kamboj, et al.
Published: (2024-01-01)